Dr Patrick Vermersch discusses teriflunomide’s role in the treatment of multiple sclerosis, the focus of his article recently published in European Neurological Review.
View his article here.
Speaker disclosures: Consultant and/or support for research from: Novartis, Biogen, Sanofi,
Teva, Servier, Roche and Celgene.
Filmed at the 3rd Congress of the European Academy of Neurology (EAN), Amsterdam, June 2017.